Docetaxel 100 versus 80 mg/m2 as adjuvant treatments of early breast cancer: an exploratory analysis of a randomised trial.

P Bono, P-L Kellokumpu-Lehtinen, T Alanko, R Kokko, R Asola, T Turpeenniemi-Hujanen, S Jyrkkiö, V Kataja, M Leinonen, H Joensuu

Journal: Annals of oncology : official journal of the European Society for Medical Oncology 2009;20(3):595-6

PMID: 19153112

Free Full Text on Elsevier Science View on PubMed

Abstract

DOI: 10.1093/annonc/mdn771

Link outs

Free resources

Full Text Sources:

https://linkinghub.elsevier.com/retrieve/pii/S0923...

Medical:

https://medlineplus.gov/breastcancer.html

Subscription / membership required

Full Text Sources:

http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=linko...

MeSH Terms: Antineoplastic Agents, Phytogenic, Breast Neoplasms, Chemotherapy, Adjuvant, Docetaxel, Dose-Response Relationship, Drug, Female, Humans, Taxoids

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.